Skip to the page

Data / Form D filings / EYE-Pharma LLC

EYE-Pharma LLC: Form D filing

EYE-Pharma LLC, a pharmaceuticals company in Little Rock, AR, filed a Form D with the SEC in 2014. The latest, on February 5, 2014, reports $145,500 sold of a $3 million offering to 3 investors.

Find out what EYE-Pharma LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4301 WEST MARKHAM STREET, #831, Little Rock, AR, 72205
Phone
(941) 323-6577
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Arkansas
Year incorporated
2013
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1597998

The full lists. Form D filings in Arkansas: 214 rows, $10.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 5, 2014New notice$3,000,000$145,500$2,854,5003Jan 29, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dr. Sunil GuptaExecutive Officer, Director
Dr. Shirish L. ShahExecutive Officer
Tom L. FitzgeraldExecutive Officer
Brett L. MatthewsExecutive Officer, Director
Michael GeranenExecutive Officer, Director
Dr. Joe L. FixExecutive Officer, Director
Terrence L. ShockleyExecutive Officer
Dr. James K. HendrenDirector

Every Form D from the week of Feb 3, 2014 · All recent filings in Arkansas · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what EYE-Pharma LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.